A5080135607- Mechanical Circulatory Support Devices
- Transplantation: Methods and Outcomes
- Cardiac Structural Anomalies and Repair
- Cardiac pacing and defibrillation studies
- Heart Failure Treatment and Management
- Cardiac Arrest and Resuscitation
- Atrial Fibrillation Management and Outcomes
- Viral Infections and Immunology Research
- Cardiac Valve Diseases and Treatments
- Agricultural Economics and Practices
- Cardiovascular Function and Risk Factors
- Agricultural pest management studies
- Cardiovascular Issues in Pregnancy
- Cardiac Arrhythmias and Treatments
- Congenital Heart Disease Studies
- Pulmonary Hypertension Research and Treatments
- Cardiac tumors and thrombi
- Genetic and Environmental Crop Studies
- Organ Transplantation Techniques and Outcomes
- Infective Endocarditis Diagnosis and Management
- Renal Transplantation Outcomes and Treatments
- Acute Myocardial Infarction Research
- Cardiac Imaging and Diagnostics
- Coronary Interventions and Diagnostics
- Cardiac, Anesthesia and Surgical Outcomes
Banner - University Medical Center Phoenix
2019-2024
University of Arizona
2018-2024
Banner Health
2020-2024
University of Phoenix
2018-2023
Mayo Clinic in Arizona
2009-2021
Phoenix (United States)
2021
Banner - University Medical Center Tucson
2019
Icahn School of Medicine at Mount Sinai
2016-2018
Geisinger Medical Center
2018
St. Luke's-Roosevelt Hospital Center
2017
In a retrospective survey, 487 research projects approved by the Central Oxford Research Ethics Committee between 1984 and 1987, were studied for evidence of publication bias. As May, 1990, 285 studies had been analysed investigators, 52% these published. Studies with statistically significant results more likely to be published than those finding no difference study groups (adjusted odds ratio [OR] 2·32; 95% confidence interval [Cl] 1·25-4·28). also lead greater number publications...
Abstract Background Catheter ablation is widely accepted intervention for atrial fibrillation (AF) refractory to antiarrhythmic drugs, but limited data are available regarding contemporary trends in major complications and in‐hospital mortality due the procedure. This study was aimed at exploring temporal of mortality, complications, impact hospital volume on frequency AF ablation–related outcomes. Methods The Nationwide Inpatient Sample database utilized identify patients treated with...
Background Atrial fibrillation is the most common arrhythmia worldwide. Data regarding 30‐day readmission rates after discharge for atrial remain poorly reported. Methods and Results The Nationwide Readmission Database (2010–2014) was queried using International Classification of Diseases, Ninth Revision ( ICD‐9 ) codes to identify study population. Incidence, etiologies predictors readmissions, cost care were analyzed. Among 1 723 378 patients who survived discharge, 249 343 (14.4%)...
Device-related hemolysis leading to anemia is a recognized chronic complication of left ventricular assist device (LVAD). With the increased usage LVAD in management end-stage heart failure, an number complications are being recognized. We present case where combination elevated mean arterial pressure and development aortic regurgitation resulted hemolysis, power spikes, anemia, mimicking thrombus, resulting diagnostic dilemma.
This is the first reported case of full biventricular mechanical circulatory support with combination Impella and Protek Duo, which a dual-lumen cannula inserted via right internal jugular vein, its proximal inflow lumen positioned in atrium distal main pulmonary artery. These lumens are connected paracorporeal TandemHeart pump allowing flows up to 5 L/min. The alternative percutaneous option for ventricular RP (Abiomed), has be placed femoral preventing ambulation. axillary vein positions...
Abstract Background Understanding the factors associated with early readmissions following atrial flutter (AFL) ablation is critical to reduce cost and improving quality of life in AFL patients. Method The study cohort was derived from national readmission database 2013–2014. International Classification Diseases, 9th Revision (ICD‐9‐CM) diagnosis code 427.32 procedure 37.34 were used identify catheter ablation, respectively. primary secondary outcomes 90‐day complications including...
Heart failure impacts patients' functional capabilities, ultimately leading to frailty. The use of a left ventricular assist device (LVAD) is acceptable as both destination therapy and bridge transplant in heart management. We aim evaluate the prognostic value Clinical Frailty Scale (CFS) on outcomes older patients undergoing implantation LVAD.
The Thoratec Implantable Ventricular Assist Device (IVAD) is the only FDA-approved intracorporeal biventricular cardiac assist device. It a titanium-coated version of its predecessor, Paracorporeal (PVAD). blood pump compatible with portable TLC-II driver, making home discharge feasible.Nine consecutive patients were implanted IVAD from June 2005 through March 2006. indications for support acute heart failure in 6 cases and chronic 3 cases. All managed maximal medical therapies including...